• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards | Inspections
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
 
Trade NameHEALON SODIUM HYALURONATE OPHTHALMIC VISCOELASTIC DEVICES (OVD), HEALON ENDOCOAT OPHTHALMIC VISCOELASTIC DEVICE (OVD) (3
Classification Nameaid, surgical, viscoelastic
Regulation Number886.4275
ApplicantABBOTT MEDICAL OPTICS INC
PMA NumberP810031
Supplement NumberS046
Date Received10/22/2012
Decision Date01/11/2013
Product Code
LZP[ Registered Establishments with LZP ]
Advisory Committee Ophthalmic
Supplement Typereal-time process
Supplement Reason change design/components/specifications - other
Expedited Review Granted? No
Combination Product Yes
Approval Order Statement 
Approval for a new secondary carton package containing one heaton ovd (0. 55 ml) and one heaton® endocoat ovd (0. 85 ml). The device, as modified, will be marketed under the trade name heaton duet dual pack and is indicated for: healon: heaton® ovd is intended for use as a surgical aid in cataract extraction (intra- and extracapsular), iol implantation, corneal transplant, glaucoma filtration and retinal attachment surgery. Heaton endocoat: heaton® endocoat ovd, model vt585 is intended for use as a surgical aid in patients undergoing ophthalmic anterior segment procedures including: 1) cataract surgery with an intraocular lens; 2) cataract surgery without an intraocular lens; and 3) secondary intraocular lens implantation. Heaton® endocoat ovd maintains a deep chamber during anterior segment surgery, aids in tissue manipulation during surgery, enhances visualization during the surgical procedure and protects the corneal endothelium and other ocular tissue. The viscoelasticity of the solution maintains the normal position of the vitreous face and prevents formation of a flat chamber during surgery. It may also be used to coat intraocular lenses and insertion instruments prior to intraocular lens implantation.
-
-